National Cancer Center Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1989-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.ncc.re.kr
ICG-coated Endoscopic Clip for Tumor Localization
- Conditions
- Colorectal Neoplasms
- First Posted Date
- 2019-04-23
- Last Posted Date
- 2019-11-27
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 30
- Registration Number
- NCT03924349
- Locations
- 🇰🇷
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
Non-exposure Simple Suturing EFTR (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2)
- Conditions
- Early Gastric Cancer
- First Posted Date
- 2019-02-12
- Last Posted Date
- 2019-02-12
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 88
- Registration Number
- NCT03837301
- Locations
- 🇰🇷
National Cancer Center, Goyang, Korea, Republic of
Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Drug: CA and Nivolumab
- First Posted Date
- 2019-01-17
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 22
- Registration Number
- NCT03808480
- Locations
- 🇰🇷
National Cancer Center, Goyang-Si, Gyeonggi-do, Korea, Republic of
Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
- Conditions
- Triple Negative Breast Cancer
- Interventions
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2023-11-09
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 284
- Registration Number
- NCT03756298
- Locations
- 🇰🇷
Korea University, Guro hospital, Seoul, Korea, Republic of
Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer
- First Posted Date
- 2018-11-27
- Last Posted Date
- 2021-03-11
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 119
- Registration Number
- NCT03755141
- Locations
- 🇰🇷
Korea University, Guro hospital, Seoul, Korea, Republic of
Study of Lorlatinib in ROS1 Rearranged NSCLC
- First Posted Date
- 2018-08-02
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 35
- Registration Number
- NCT03612154
- Locations
- 🇰🇷
National Cancer Center, Goyang-Si, Gyeonggi-do, Korea, Republic of
Curative Proton Beam Therapy for Patients With Liver Metastasis of Colorectal Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2018-07-05
- Last Posted Date
- 2019-08-21
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 30
- Registration Number
- NCT03577665
- Locations
- 🇰🇷
National Cancer Center Korea, Goyang-si, Gyeonggi-do, Korea, Republic of
Curative Proton Beam Therapy for Patients With Lung Metastasis of Colorectal Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2018-06-25
- Last Posted Date
- 2019-08-21
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 36
- Registration Number
- NCT03566355
- Locations
- 🇰🇷
National Cancer Center Korea, Goyang-si, Gyeonggi-do, Korea, Republic of
Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer
- Conditions
- Breast CancerInvasive Breast Cancer
- Interventions
- First Posted Date
- 2018-04-13
- Last Posted Date
- 2018-04-13
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 114
- Registration Number
- NCT03497702
- Locations
- 🇰🇷
National Cancer Center, Goyang-si, Korea, Republic of
Korean Lung Cancer Screening Project
- Conditions
- Lung Cancer
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2018-01-09
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 8000
- Registration Number
- NCT03394703
- Locations
- 🇰🇷
National Cancer Center, Goyang, Gyeonggi, Korea, Republic of